Related references
Note: Only part of the references are listed.Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions
Cristina Mantovani et al.
FRONTIERS IN ONCOLOGY (2021)
Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
Shau-Hsuan Li et al.
CANCERS (2021)
Radiotherapy treatment for lung cancer: Current status and future directions
Shalini K. Vinod et al.
RESPIROLOGY (2020)
A narrative review of evolving roles of radiotherapy in advanced non-small cell lung cancer: from palliative care to active player
Yue Zhou et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Prognostic Significance of 18F-FDG PET/CT Metabolic Parameters and Tumor Galectin-1 Expression in Patients With Surgically Resected Lung Adenocarcinoma
Hongna Zheng et al.
CLINICAL LUNG CANCER (2019)
The evolving role of radiotherapy in non-small cell lung cancer
Sean Brown et al.
BRITISH JOURNAL OF RADIOLOGY (2019)
Predictive importance of galectin-3 for recurrence of non-small cell lung cancer
Yoko Kataoka et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2019)
Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression
Wu Zhou et al.
BMC CANCER (2018)
Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
Shang-Yu Chou et al.
BMC CANCER (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
Jennifer L. Shah et al.
SEMINARS IN RADIATION ONCOLOGY (2017)
Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer
Hong-Yi Kuo et al.
GLYCOBIOLOGY (2016)
Reversal of galectin-1 gene silencing on resistance to cisplatin in human lung adenocarcinoma A549 cells
Lei Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin
Ling-Yen Chung et al.
ONCOTARGET (2015)
Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness
Xuefeng Zhou et al.
ONCOTARGET (2015)
New radiotherapy approaches in locally advanced non-small cell lung cancer
Marianna Christodoulou et al.
EUROPEAN JOURNAL OF CANCER (2014)
Clinical relevance of galectin-1 expression in non-small cell lung cancer patients
Maria Jose Carlini et al.
LUNG CANCER (2014)
Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer
Iris A. Schulkens et al.
PLOS ONE (2014)
Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway
Ya-Ling Hsu et al.
CARCINOGENESIS (2013)
Galectin-1 Is an Independent Prognostic Factor for Local Recurrence and Survival After Definitive Radiation Therapy for Patients With Squamous Cell Carcinoma of the Uterine Cervix
Eng-Yen Huang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2
Ling-Yen Chung et al.
CLINICAL CANCER RESEARCH (2012)
A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells
E-Y Huang et al.
CELL DEATH & DISEASE (2012)
Galectin-3 and cyclin D1 expression in non-small cell lung cancer
Monika Kosacka et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
The Role of Tumor Stroma in Cancer Progression and Prognosis Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
Anne Auperin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Gender, Histology, and Time of Diagnosis Are Important Factors for Prognosis Analysis of 1499 Never-Smokers with Advanced Non-small Cell Lung Cancer in Japan
Tomoya Kawaguchi et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Survival Differences by Gender for Resected Non-small Cell Lung Cancer A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry Study
Hiroyuki Sakurai et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Galectin-1-Mediated Tumor Invasion and Metastasis, Up-Regulated Matrix Metalloproteinase Expression, and Reorganized Actin Cytoskeletons
Ming-Heng Wu et al.
MOLECULAR CANCER RESEARCH (2009)
Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung
A Mathieu et al.
MODERN PATHOLOGY (2005)
Share Paper
